02:49 , Jan 5, 2019 |  BioCentury  |  Finance

Ready to launch

  The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record...
00:20 , Aug 10, 2018 |  BC Week In Review  |  Clinical News

Cassiopea planning NDA for acne candidate after Phase III meets endpoints

Cassiopea S.p.A. (SIX:SKIN) said twice-daily topical Winlevi 1% clascoterone (CB-03-01) for 12 weeks met the three co-primary endpoints vs. placebo in both the Phase III Study 25 and Study 26 to treat acne. The company...
07:00 , Oct 24, 2016 |  BioCentury  |  Finance

Luck favors the prepared

A year’s worth of preparation for a U.S. IPO put Swiss biotech AC Immune S.A. (NASDAQ:ACIU) in the perfect position to thread the needle between the Brexit fallout and volatility around the U.S. elections. That...
08:00 , Jan 21, 2016 |  BC Innovations  |  Finance

Italy's velocity factor

After five years of building a portfolio of research programs, Italian tech transfer company TTFactor s.r.l. can now turn to a homegrown supply of seed funding following the launch of BiovelocITA, the country's first biotech...
07:00 , Oct 5, 2015 |  BioCentury  |  Finance

Volatile, not futile

Bankers and buysiders are not ready to call the end of the biotech bull on the heels of the sector's worst quarter in more than 13 years. But they do expect volatility to persist through...
07:00 , Jul 20, 2015 |  BC Week In Review  |  Financial News

Cassiopea completes IPO

Cassiopea S.p.A. (SIX:SKIN), Lainate, Italy   Business: Dermatology, Infectious   Date completed: 2015-07-01   Type: IPO   Raised: CHF175.6 million ($187 million)   Shares: 5.2 million   Price: CHF34   Shares after offering: 10 million...
07:00 , Jun 29, 2015 |  BC Week In Review  |  Financial News

Cassiopea amends IPO

Cassiopea S.p.A. , Lainate, Italy   Business: Dermatology, Infectious   Date announced: 2015-06-22   Type: IPO   To be raised: Up to CHF192 million ($208.6 million)   Shares: 4.8 million   Price: CHF30-CHF40   Underwriters:...
07:00 , Jun 15, 2015 |  BC Week In Review  |  Financial News

Cassiopea proposes IPO

Cassiopea S.p.A. , Lainate, Italy   Business: Dermatology, Infectious   Date announced: 2015-06-09   Type: IPO   To be raised: TBD   Shares: TBD   Price: TBD   Note: Cassiopea, a majority-owned subsidiary of Cosmo...